Search research articles
Contact Us
Filters
Showing results (21-30 of 82) with videos related to
Page
of 9
Sort By:
JAMA Oncology
|
June 9, 2016
Evaluation of Pancreatic Cancer Clinical Trials and Benchmarks for Clinically Meaningful Future Trials: A Systematic Review
Lola Rahib, Julie M Fleshman, Lynn M Matrisian, et al.
Clinical Colorectal Cancer
|
February 19, 2008
Phase II trial of T138067, a novel microtubule inhibitor, in patients with metastatic, refractory colorectal carcinoma
Jordan D Berlin, Alan Venook, Emily Bergsland, et al.
Journal of Geriatric Oncology
|
December 22, 2018
Advanced pancreatic cancer clinical trials: The continued underrepresentation of older patients
Maya N White, Efrat Dotan, Paul J Catalano, et al.
The American Journal of Surgical Pathology
|
February 1, 2019
Impact of Peritoneal Metastasis on Survival of Patients With Small Intestinal Neuroendocrine Tumor
Martha Frances Wright, Justin Cates, Raul S Gonzalez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2002
Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297
Jordan D Berlin, Paul Catalano, James P Thomas, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
January 10, 2013
Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement
Roderich E Schwarz, Jordan D Berlin, Heinz J Lenz, et al.
Investigational New Drugs
|
January 30, 2018
First-in-human phase I dose escalation study of MK-8033 in patients with advanced solid tumors
Vicki L Keedy, Heinz-Josef Lenz, Leonard Saltz, et al.
American Journal of Cancer Research
|
November 9, 2020
Evaluation of determinants for age disparities in the survival improvement of colon cancer: results from a cohort of more than 486,000 patients in the United States
Fa Chen, Fei Wang, Christina E Bailey, et al.
Clinical Colorectal Cancer
|
June 19, 2013
Clinical utility of KRAS and BRAF mutations in a cohort of patients with colorectal neoplasms submitted for microsatellite instability testing
Allison M Cushman-Vokoun, Daniel G Stover, Zhiguo Zhao, et al.
Gastrointestinal Cancer Research : GCR
|
October 19, 2012
A phase I study of cetuximab in combination with gemcitabine and radiation for locally advanced pancreatic cancer
A Bapsi Chakravarthy, Chiao Jillian Tsai, Nathan O'Brien, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 82) with videos related to
Sort By:
Page
of 9
JAMA Oncology
|
June 9, 2016
Evaluation of Pancreatic Cancer Clinical Trials and Benchmarks for Clinically Meaningful Future Trials: A Systematic Review
Lola Rahib, Julie M Fleshman, Lynn M Matrisian, et al.
Clinical Colorectal Cancer
|
February 19, 2008
Phase II trial of T138067, a novel microtubule inhibitor, in patients with metastatic, refractory colorectal carcinoma
Jordan D Berlin, Alan Venook, Emily Bergsland, et al.
Journal of Geriatric Oncology
|
December 22, 2018
Advanced pancreatic cancer clinical trials: The continued underrepresentation of older patients
Maya N White, Efrat Dotan, Paul J Catalano, et al.
The American Journal of Surgical Pathology
|
February 1, 2019
Impact of Peritoneal Metastasis on Survival of Patients With Small Intestinal Neuroendocrine Tumor
Martha Frances Wright, Justin Cates, Raul S Gonzalez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2002
Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297
Jordan D Berlin, Paul Catalano, James P Thomas, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
January 10, 2013
Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement
Roderich E Schwarz, Jordan D Berlin, Heinz J Lenz, et al.
Investigational New Drugs
|
January 30, 2018
First-in-human phase I dose escalation study of MK-8033 in patients with advanced solid tumors
Vicki L Keedy, Heinz-Josef Lenz, Leonard Saltz, et al.
American Journal of Cancer Research
|
November 9, 2020
Evaluation of determinants for age disparities in the survival improvement of colon cancer: results from a cohort of more than 486,000 patients in the United States
Fa Chen, Fei Wang, Christina E Bailey, et al.
Clinical Colorectal Cancer
|
June 19, 2013
Clinical utility of KRAS and BRAF mutations in a cohort of patients with colorectal neoplasms submitted for microsatellite instability testing
Allison M Cushman-Vokoun, Daniel G Stover, Zhiguo Zhao, et al.
Gastrointestinal Cancer Research : GCR
|
October 19, 2012
A phase I study of cetuximab in combination with gemcitabine and radiation for locally advanced pancreatic cancer
A Bapsi Chakravarthy, Chiao Jillian Tsai, Nathan O'Brien, et al.
Page
of 9